Effectiveness of GnRH Antagonists and Agonists in Patients with Hormone-Sensitive Prostate Cancer: A Retrospective Study.
Zhenghao LiuChunguang YangXing ZengChunjin KeJihua TianZhihua WangZhiquan HuPublished in: Applied bionics and biomechanics (2022)
The PSA control rate of HSPC patients treated with GnRH antagonist is significantly higher than that of the agonist group, and the use of GnRH antagonist is an independent predictor of PSA control rate.